Exploring the melanoma survivorship experience: a qualitative study.

Exploring the melanoma survivorship experience: a qualitative study.
Br J Dermatol. 2021 Feb 05;:
Authors: Wolner ZJ, Flowers NI, Yushak ML, Chen SC, Yeung H
Abstract
Cutaneous melanomas are the fifth most common cancer in the United States and the United Kingdom, with a 5-year relative survival of 87-93%.1,2 Targeted and immune checkpoint therapies have further expanded the number of advanced melanoma survivors. Cancer survivorship recommendations have been published by Macmillan Cancer Support; yet programs for melanoma survivors in the US are still in their infancy.3 We aimed to explore experiences and challenges that US patients diagnosed with melanoma experienced in a tertiary cancer centre using in-depth interviews.
PMID: 33544884 [PubMed - as supplied by publisher]

Source: The British Journal of Dermatology - February 5, 2021 Category: Dermatology Authors: Wolner ZJ, Flowers NI, Yushak ML, Chen SC, Yeung H Tags: Br J Dermatol Source Type: research